Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

Boehringer's phase 3 schizophrenia program misses primary goal
Fierce Biotech
Thu, 01/16/25 - 09:39 pm
Tags:
Boehringer Ingelheim, schizophrenia, clinical trials, iclepertin
Boehringer Ingelheim drops obesity drug from Gubra partnership
Fierce Biotech
Thu, 10/31/24 - 10:45 pm
Tags:
Boehringer Ingelheim, Gubra, obesity
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Fierce Biotech
Tue, 10/15/24 - 10:17 am
Tags:
Notable Labs, Boehringer Ingelheim, oncology, bankruptcy, volasertib
Boehringer unveils $607M deal to land Circle's preclinical cancer program
Fierce Biotech
Wed, 10/9/24 - 09:55 am
Tags:
Boehringer Ingelheim, Circle Pharma, cancer, drug development
Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status
Clinical Trials Arena
Tue, 10/8/24 - 09:56 am
Tags:
Boehringer Ingelheim, MASH, clinical trials, survodutide
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
Tags:
R&D, obesity, weight loss, Novo Nordisk, Eli Lilly, Roche, Boehringer Ingelheim
Boehringer Ingelheim and Veeva: A data partnership for One Medicine
Pharmaphorum
Fri, 10/4/24 - 09:18 am
Tags:
Boehringer Ingelheim, Veeva, One Medicine Platform, Clinical Data
Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor
Fierce Biotech
Mon, 09/16/24 - 10:57 am
Tags:
Boehringer Ingelheim, IPF, clinical trials, nerandomilast
Boehringer Ingelheim reports positive results from trial of HER2 lung cancer drug
Clinical Trials Arena
Tue, 09/10/24 - 08:35 am
Tags:
Boehringer Ingelheim, clinical trials, zongertinib, non-small cell lung cancer
Boehringer adds to cancer drug pipeline with deal for startup Nerio
BioPharma Dive
Mon, 07/29/24 - 11:01 am
Tags:
Boehringer Ingelheim, M&A, Nerio Therapeutics, immuno-oncology
GoodRx teams with Boehringer on Humira biosimilar
Axios
Thu, 07/18/24 - 11:21 am
Tags:
GoodRx, Boehringer Ingelheim, biosimilars, Humira
Boehringer backs Brainomix AI software for lung fibrosis
Pharmaphorum
Thu, 07/18/24 - 11:08 am
Tags:
Boehringer Ingelheim, digital health, lung fibrosis, Brainomix, artificial intelligence
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling
BioSpace
Mon, 07/8/24 - 11:38 am
Tags:
Boehringer Ingelheim, Inflation Reduction Act, legal, Medicare, drug pricing
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena
Tue, 07/2/24 - 11:19 am
Tags:
Boehringer Ingelheim, Gubra, clinical trials, BI 3034701, obesity
With 2 planned launches, Boehringer Ingelheim looks to make a name for itself in oncology
Fierce Pharma
Mon, 06/10/24 - 06:07 pm
Tags:
Boehringer Ingelheim, oncology, ASCO 2024, DDLPS, glioblastoma
Boehringer, Lilly face off in MASH at EASL
Pharmaphorum
Mon, 06/10/24 - 11:14 am
Tags:
Eli Lilly, Boehringer Ingelheim, MASH, EASL, tirzepatide, survodutide
Boehringer, Zealand’s GLP-1 MASH Data ‘Unintentionally’ Published by Medical Congress Website
BioSpace
Thu, 06/6/24 - 11:48 am
Tags:
Zealand Pharma, Boehringer Ingelheim, MASH, survodutide, clinical trials
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
Tags:
R&D, Novartis, Argo Biopharmaceutical, Roche, MOMA Therapeutics, Boehringer Ingelheim, Suzhou Ribo Life Science, Eli Lilly, Isomorphic Labs, Merus, Gilead Sciences, Novo Nordisk, Neomorph, AbbVie, Umoja Biopharma, Merck KGaA, Caris Life Sciences, Voyager Therapeutics
Boehringer outlines up to $33.6m for cancer asset from OSE Therapeutics
Clinical Trials Arena
Thu, 05/23/24 - 09:43 pm
Tags:
Boehringer Ingelheim, OSE Immunotherapeutics, oncology
Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset
Fierce Biotech
Wed, 05/22/24 - 11:31 am
Tags:
Boehringer Ingelheim, OSE Immunotherapeutics, cardiovascular disease, solid tumors

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.